TABLE 2.
Characteristics Related to Cost-effectiveness Analysis a
| Lead Author (Year) | Comparator | Payment Perspective | Procedural Cost | Time Until Hip Arthroscopy Is Cost-effective | ICER, $/QALY | QALY Gained | Arthroscopy Cost per QALY, $/QALY |
|---|---|---|---|---|---|---|---|
| Clement (2014) 4 | None | HCS | $6840 | <1 | NA |
|
|
| Griffin (2018) 14 | Personalized hip therapy | HCS | A: $3957 C: $872 | Never | $592,500 | A: 0.62 ± 0.25 C: 0.58 ± 0.24 |
NR |
| Personalized hip therapy | Societal | A: $3944 C: $1311 | Never | Surgery is both more expensive and less effective than rehabilitation | NR | NA | |
| Lodhia (2016) 20 | Rehabilitation | Societal | A: $27,816 ± $8518 C: $25,104 ± $5572 | NR | $997 | A: 21.8 ± 4.9 C:17.8 ± 3.2 |
$1276 |
| Mather (2018) 22 | Nonoperative care | Societal | A: $24,626 ± $10,949 C: $97,570 ± $15,631 | 1.87 y | Surgery is both cheaper and more effective than nonoperative care | A: 8.5 ± 0.5 C: 6.5 ± 0.4 |
$2897 |
| Scott (2020) 36 | Nonoperative care | HCS | A: $14,267 ± $7188 C: $29,412 ± $2664 | NR | NR | NR | NR |
| Shearer (2012) 37 | Nonoperative care | HCS | A: $13,817 C: $292 | 1.1 y | $25,302 without OA; $92,697 with OA | 0.2 ± 0.05 | NR |
a Data are presented as mean ± SD. All costs are reported as 2019 US dollar. A, hip arthroscopy; C, comparator; HCS, health care system; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year; OA, osteoarthritis; NA, not applicable; NR, not reported.